RxDoctor Payments DataLook up a doctor →

Charles Daley, MD

Pulmonary Disease · Denver, CONPI 1316027915

Payments from drug & device makers

$590,659in general payments, 2019–2025

Across 401 payments — averaging $1472.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Insmed, Inc.$318K
  • Paratek Pharmaceuticals, Inc.$161K
  • Verona Pharma, Inc.$47K
  • Mannkind Corporation$41K
  • Biomerieux Inc$16K
  • Merck$2K
  • plus $6K from 13 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$590,659 in reported general payments places this provider in the 95th percentile of 248 pulmonary disease providers in Colorado.

See all pulmonary disease providers in Colorado

Medicare billing

Part B allowed, 2024
$46,667
Medicare patients
163
Services billed
350

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in Denver

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →